Sponsor Deadline
Posted: 4/18/2022

2022 IBD Competitive Grant Program

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

The intent of the RFP is to support/fund proposals that focus on the below areas:

• Real world effectiveness and safety of tofacitinib in moderately to severely active ulcerative colitis; examples would include comparative effectiveness, long term effectiveness and safety

• Use of tofacitinib in certain subpopulations: examples would include extra-intestinal manifestations, pouchitis

• Approaches to improving IBD management; examples would include treating to target; impact and outcomes related to healthcare disparities

Full Proposal Deadline: February 7th, 2022

Eligibility Requirements

Geographic Scope: United States

To be eligible: • The institution and principal investigator (PI) must be based in one of the eligible countries noted above. • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution. • Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria.

Amount Description

• Individual projects requesting up to $150,000 will be considered. Pfizer anticipates awarding up to 3 grants • The amount of the grant Pfizer will be prepared to fund for any project will depend upon the expert review panel’s evaluation of the proposal and costs involved, and will be stated clearly in the approval notification

Amount
$150,000
Funding Type
Eligibility
Posted
4/18/2022
Deadline
Sponsor: